Deep dive into RBAC vs ReBAC for enterprise sso. Learn which authorization model fits your ciam strategy and how to avoid role explosion in complex apps.

Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the market? This article walks through what the current numbers may be telling ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Bitcoin's deflationary nature makes it unsuitable as a global currency but ideal for long-term wealth preservation and ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

DeFi has evolved from 2020’s yield chaos into real financial infrastructure. Here’s how stablecoins, RWAs, and institutions ...

We are always amused that we can run emulations or virtual copies of yesterday’s computers on our modern computers. In fact, there is so much power at your command now that you can run, say, ...

Images of plants painted on pottery made up to 8,000 years ago may be the earliest example of humans’ mathematical thought, a study has found.

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Basic earnings per share (EPS) tells investors how much of a firm's net income ...